Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
about
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human GutThe virome in host health and diseaseDefining dysbiosis and its influence on host immunity and diseaseA Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing SpondylitisPotential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococciClinical Implications of Basic Science Discoveries: Immune Homeostasis and the Microbiome-Dietary and Therapeutic Modulation and Implications for TransplantationMicroorganisms with claimed probiotic properties: an overview of recent literature.Deciphering the tête-à-tête between the microbiota and the immune system.Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.Fecal transplant policy and legislation.Microbiota modulation of myeloid cells in cancer therapyFecal microbiota transplantation in treating Clostridium difficile infection.Public health evolutionary biology of antimicrobial resistance: priorities for interventionThe role of the microbiota in inflammation, carcinogenesis, and cancer therapy.The microbiota and microbiome in aging: potential implications in health and age-related diseasesMicrobiota-mediated inflammation and antimicrobial defense in the intestine.Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.Intestinal microbiota could transfer host Gut characteristics from pigs to mice.Intrinsic Defense Mechanisms of the Intestinal EpitheliumTLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.The gastrointestinal tract microbiome and potential link to Alzheimer's disease.Microbiome sequencing: challenges and opportunities for molecular medicine.Small Molecules That Sabotage Bacterial Virulence.Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook.The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium.A small-molecule antivirulence agent for treating Clostridium difficile infection.Enterococci and Their Interactions with the Intestinal Microbiome.Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring.Intestinal microbiota: a novel perspective in colorectal cancer biotherapeuticsFrom metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn's disease
P2860
Q26742179-8729EA55-8137-4A51-9995-14F908F51F40Q26824795-DC5EFC4D-4251-4D66-847A-127166142DADQ26851835-58B13E8A-C3A2-482E-9B66-1E7C64745672Q28069331-86ADC4B7-FE6E-4DF1-A405-52F63A07C991Q28085151-80461B8F-7097-4A7C-907A-6D07DD060D56Q28085515-8BE421F1-A879-4E11-BD48-4D18217FC21EQ33742439-99AF3795-E2E6-4C44-A32F-E1D094AC01D7Q34311731-01A79518-6652-4077-8D80-34F3F43B7DACQ34589700-278A63F2-39DB-4CCA-8334-FED2097721DCQ34827720-3A5A4440-FE11-47C5-BB48-AF6026BADB87Q35073092-7C375D45-58C2-4BF0-89BC-CEEE1079D4F2Q35168209-5EDBD0EA-56D8-4017-AEA8-2DBF658FDF8CQ35236703-E9E4E78D-C76B-47E4-8176-FD88F7843C1FQ35346303-2B1B695C-80DF-4399-9FCB-B30C4B1167B9Q35528261-08DB8714-6AEB-4886-B418-27A74902C8F5Q35541605-BD95660C-2988-4AA5-BCF3-B749BFE1FB71Q35605686-30C23BAF-E3A0-4F0D-A0C5-3AD420F61F93Q36001287-F551BEA0-CEA4-49DD-9FBA-148B4927C9D8Q36160705-4D77A3F5-6AC3-48ED-94AD-D2A2F417F8F3Q36883488-FD874615-946C-43B4-A912-D08A4777B7BCQ37190661-35799560-AFB5-4026-B4FA-0BB9A706BFC2Q38207585-C605A89D-7A8C-479F-90C6-61B8ABC1924AQ38820262-21A4FF43-FCCD-4733-A67E-D59F6DA46B75Q39139601-AC9CE5F9-B231-4AB9-9011-619CBA9423F5Q39414517-14253EDB-ADC7-4C5B-9954-2573499B88E3Q40063718-664F8813-3D76-4342-98C9-BDC83373F1B8Q40216982-B3F11BB1-75F0-465B-81B3-9494D059F329Q40984710-AC714761-BF77-4175-A3CE-89F5E67FBBE2Q46819823-1EF6069F-395D-469C-977F-657873BF624EQ47300508-1CBD19F8-66FA-4A28-AC33-062614A6A5A6Q49733575-965B40BC-1ED3-41BB-AC75-4E706A250091Q51731616-2ECBBA81-A92F-4BF0-8DC6-110E21114739Q57169731-96B817BC-43A6-4009-B95E-D8ABBD80351DQ57971637-1CE98453-365F-499F-B67E-66EE60A4B856
P2860
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@ast
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@en
type
label
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@ast
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@en
prefLabel
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@ast
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@en
P2860
P356
P1433
P1476
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.
@en
P2093
P2860
P2888
P304
P356
10.1038/MI.2013.117
P577
2014-01-08T00:00:00Z
P5875
P6179
1036949660